Title
Category
Credits
Event date
Cost
  • CME Activities
  • Critical Care
  • Disorders
  • EEG
  • Emergency
  • Neurology
  • Seizure
  • Status Epilepticus
  • Telemedicine
  • Participation
$0.00
  • CME Activities
  • Neurology
  • Sleep
  • Telemedicine
  • Participation
$0.00
  • CME Activities
  • Critical Care
  • Disorders
  • EEG
  • Neurology
  • Seizure
  • Telemedicine
  • Participation
$0.00
  • Alteplase
  • Best Practices
  • CME Activities
  • Emergency
  • Stroke
  • Telemedicine
  • Thrombolysis
  • Thrombolytics
  • Participation
$0.00
  • CME Activities
  • COVID-19
  • Emergency
  • Stroke
  • Telemedicine
  • Participation
$0.00
  • CME Activities
  • Ethics
  • Medicolegal
  • Telemedicine
  • Participation
$0.00
Join TeleSpecialists’ TeleNeurologist, Dr. Michelle Boudreau, as she reviews the medicolegal and ethical aspects of telemedicine to increase competence and improve patient care. Dr. Boudreau will cover the following topics in this talk: obtaining informed consent obtaining appropriate licensure and regulations respect for patients beneficence nonmaleficence justice when practicing telemedicine
  • Alteplase
  • Best Practices
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Telemedicine
  • Participation
$0.00
Join us in celebrating National Stroke Awareness Month and National Neuroscience Nurses Week as our panel reviews several TeleSpecialists’ best practice recommendations and discusses new focus areas for the improvement of stroke care.
  • CME Activities
  • Critical Care
  • Emergency
  • Imaging
  • Neurointervention
  • Neurology
  • Stroke
  • Telemedicine
  • Thrombolysis
  • Thrombolytics
  • Participation
$0.00
Join TeleSpecialists TeleNeurologist Sam Saha, MD as he shares details about the latest clinical trials supporting imaging-guided thrombolysis and thrombectomy decision-making that have demonstrated net benefit in subsets of patients with unknown onset of symptoms, most commonly after waking up. With wider implementation of advanced imaging augmented by artificial intelligence software, there is an argument for pushing stroke treatment boundaries long established by clinical decision-making alone.